EllTec Analysis
← Stocks
StocksCLOVHealth CareUnited StatesPremium

Clover Health Investments Corporation

A Medicare Advantage insurer navigating margin pressure in a competitive healthcare market.

Published May 2, 2026 · Updated Nov 20, 2026 · by EllTec Analysis · Wave count: Lukas Köppl · ~22 min read · How to read this analysis →

Disclosure: the EllTec Analysis Tracking Portfolio currently holds no position in CLOV. (as of Nov 20, 2026)

For information and education only. Not investment advice. See the full disclaimer for details.

In 60 seconds

Fundamentals
Clover has moved from a cash-burning growth story to a profitable, fast-growing Medicare Advantage insurer: Q3 2026 revenue rose 53%, year to date GAAP net income is 62 m USD and guidance was raised.
Strength
Revenue +53% and Medicare Advantage membership of 158,907
Risk
Thin margins: small changes in medical costs can swing results, as the drop from Q2 to Q3 profit shows
Premium
The Elliott Wave part of this analysis is for subscribers: Risk Factors · Overall Assessment

Key figures

Interactive chartClover Health Investments CorporationNASDAQ:CLOV

Switch the time frame (minutes to months), zoom, scroll and draw your own lines. The chart is provided by TradingView. Loading it transfers data such as your IP address to TradingView. Your choice is remembered in this browser. Privacy policy

More analyses in Stocks

All stock analyses →

New analyses by email

EllTec Analysis Updates: a short email whenever a new analysis is published or a scenario changes. Free, unsubscribe any time.

Newsletter →